Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Judson, Ian, Prof, Verweij, Jaap, Prof, Gelderblom, Hans, Prof, Hartmann, Jörg T, Prof, Schöffski, Patrick, Prof, Blay, Jean-Yves, Prof, Kerst, J Martijn, PhD, Sufliarsky, Josef, Prof, Whelan, Jeremy, Prof, Hohenberger, Peter, Prof, Krarup-Hansen, Anders, MD, Alcindor, Thierry, Prof, Marreaud, Sandrine, MD, Litière, Saskia, PhD, Hermans, Catherine, Fisher, Cyril, Prof, Hogendoorn, Pancras C W, Prof, dei Tos, A Paolo, Prof, van der Graaf, Winette T A, Prof
Published in The lancet oncology (01.04.2014)
Published in The lancet oncology (01.04.2014)
Get full text
Journal Article
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
van der Graaf, Winette TA, Prof, Blay, Jean-Yves, Prof, Chawla, Sant P, MD, Kim, Dong-Wan, MD, Bui-Nguyen, Binh, MD, Casali, Paolo G, MD, Schöffski, Patrick, Prof, Aglietta, Massimo, MD, Staddon, Arthur P, MD, Beppu, Yasuo, MD, Le Cesne, Axel, MD, Gelderblom, Hans, Prof, Judson, Ian R, Prof, Araki, Nobuhito, MD, Ouali, Monia, MSc, Marreaud, Sandrine, MD, Hodge, Rachel, MSc, Dewji, Mohammed R, MSc, Coens, Corneel, MSc, Demetri, George D, MD, Fletcher, Christopher D, Prof, Dei Tos, Angelo Paolo, MD, Hohenberger, Peter, Prof
Published in The Lancet (British edition) (19.05.2012)
Published in The Lancet (British edition) (19.05.2012)
Get full text
Journal Article
Web Resource
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Sternberg, Cora N, Dr, Skoneczna, Iwona, MD, Kerst, J Martijn, PhD, Albers, Peter, Prof, Fossa, Sophie D, Prof, Agerbaek, Mads, MD, Dumez, Herlinde, Prof, de Santis, Maria, MD, Théodore, Christine, MD, Leahy, Michael G, Chester, John D, Prof, Verbaeys, Antony, Prof, Daugaard, Gedske, Prof, Wood, Lori, MD, Witjes, J Alfred, PhD, de Wit, Ronald, Prof, Geoffrois, Lionel, MD, Sengelov, Lisa, DMSc, Thalmann, George, Prof, Charpentier, Danielle, MD, Rolland, Frédéric, MD, Mignot, Laurent, MD, Sundar, Santhanam, MRCP, Symonds, Paul, Prof, Graham, John, FRCP, Joly, Florence, Prof, Marreaud, Sandrine, MD, Collette, Laurence, PhD, Sylvester, Richard, ScD
Published in The lancet oncology (01.01.2015)
Published in The lancet oncology (01.01.2015)
Get full text
Journal Article
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
Woll, Penella J, Prof, Reichardt, Peter, MD, Le Cesne, Axel, MD, Bonvalot, Sylvie, MD, Azzarelli, Alberto, MD, Hoekstra, Harald J, Prof, Leahy, Michael, FRCP, Van Coevorden, Frits, MD, Verweij, Jaap, Prof, Hogendoorn, Pancras CW, Prof, Ouali, Monia, MSc, Marreaud, Sandrine, MD, Bramwell, Vivien HC, Prof, Hohenberger, Peter, Prof
Published in The lancet oncology (01.10.2012)
Published in The lancet oncology (01.10.2012)
Get full text
Journal Article
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
Schöffski, Patrick, Prof, Ray-Coquard, Isabelle Laure, MD, Cioffi, Angela, MD, Bui, Nguyen Bin, MD, Bauer, Sebastian, MD, Hartmann, Joerg Thomas, Prof, Krarup-Hansen, Anders, MD, Grünwald, Viktor, MD, Sciot, Raf, Prof, Dumez, Herlinde, Prof, Blay, Jean-Yves, Prof, Le Cesne, Axel, MD, Wanders, Jantien, MD, Hayward, Carolyn, MD, Marreaud, Sandrine, MD, Ouali, Monia, MSc, Hohenberger, Peter, Prof
Published in The lancet oncology (01.10.2011)
Published in The lancet oncology (01.10.2011)
Get full text
Journal Article